Member Info for RogueRiver

I looked at the sp a few minutes after opening and it was 203. I looked away for a minute to read a summary of the results. When I looked back, it was in the low 170s!

Should’ve gone to Specsavers - along with the rest of the swivel-eyed market.

Clearly the market was anticipating a miracle and didn’t get one. We shall probably have to wait another Q to see the sp back to where it was yesterday. Ho hum.

Now over 13% up. Surely due to more than merely the modest rise in POO.

Hmm, something this aft has piqued buyer interest.

Doubtless the market and analysts will find a way of turning this into bad news: “Glaxo’s better than expected interims mean that the anticipated influence of Elliott Management may be severely curtailed and the company will continue on the course set by Emma Walmsley”,...or some such bs.

TR64

Whatever your views on Elliott, their involvement has put a rocket up GSK’s @rse, which can only be a good thing.

Sadly, this is what happens when you throw your shares around like confetti. It is going to take more than a few sunny tweets to lift the sp. Consistency and solid results for a year will probably do it though.

Even if the interims are good, you can be sure the market will find a way of turning them into a negative.

Yeah, the market has a habit of turning good results news into bad, for no apparent reason.

@johncut

Taylor Wimpey have a history of paying exceptionally good (and well covered) special dividends, which, when added to their standard dividend, historically make them a higher payer than their rivals. If you want to build a balanced portfolio of blue chip holdings, that pay good dividends, then having a house builder in there makes perfect sense.

All companies go through good and bad patches (for a multitude of reasons) which may affect their market cap and their yield. Companies can even go under, with little or no warning. Keeping a balanced portfolio is a hedge against fluctuations in the fortunes of different sectors and different companies.

Nice to see £1 breached (well ahead of schedule too). Given all the post-covid infrastructure projects planned, plus the dividend, there would appear to be plenty of growth left in the market cap.

Don't rely on the buy/sell info on this site. It is just algorithmic guesswork, based on the sp at the time of the transaction - and often inaccurate.

I think the good news is going to have to keep flowing for a while to get the sp up, but so far so good.

ftseexplorer

Possibly, but I'm not sure why a hefty acquisition by Melrose might be considered a negative. After all, that's exactly what this company does - and evidently, very successfully.

Not sure about Walmsley, but one of the biggest enemies of the sp seems to be the strengthening pound, a simple fact which, amid the intrigue, most analysts appear to disregard.

The price exceeds the value expected by analysts. This is a great deal for Melrose. More importantly, it demonstrates the superb strategy of the company. The sp should be up a few points on this news. (Sometimes the market is utterly baffling.)

We might have expected to see a bounce on this news, but I suppose the market wants to see more proof of the pudding, having been disappointed so many times in the past. Let us hope that the positive news continues.

Bout time someone shoved a rocket up Glaxo's a***.

I doubt the FT would run a story like this on mere speculation. They obviously have some solid info.

Clearly the market believes Elliott Management may shake things up at GSK, for the better.

@Motbuck

I don’t blame you. Anyone who has followed Clipper knows that it will probably yo-yo back into the low 600s before too long. Perhaps there is another bid rumour swirling around out there at the moment.